BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.

Slides:



Advertisements
Similar presentations
Cancer—Principles and overview By Robert A. Weinberg
Advertisements

Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Chapter 19 Lecture Concepts of Genetics Tenth Edition Cancer and Regulation of the Cell Cycle.
Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
Investigating the BRCA1 Mutation F.R.E.S.H Docs. Angelina Jolie Actress, Film director, and Screenwriter Mother had Breast Cancer and died at 56 from.
By Janet Soper and its Effects in Breast Cancer and Ovarian Cancer.
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
BRCA1 Breast Cancer 1, Early Onset Simple gene, or breast/ovarian cancer’s best friend? By:Courtney Abshier.
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
34 Cancer.
BRCA2 Blue: Rad51; Green: BRCA2
ATM, Ataxia Telangiectasia, & Cancer
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
BRCA Genes Dallas Henson.
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Tumor genetics Minna Thullberg
REGULATION OF GENE EXPRESSION Chapter 18. Gene expression A gene that is expressed is “turned on”. It is actively making a product (protein or RNA). Gene.
Cancer.
BRCA2 Clark Cunningham March 26, 2015 BIOL445 American Cancer Society, eastcancer/make-a-pink-ribbon-lapel-pin,
Bloom’s Syndrome and Bloom helicase Alexandra Otto March 16, 2004.
Cancer &Oncogenes. Objectives Define the terms oncogene, proto-oncogenes and growth factors giving examples. Describe the mechanisms of activations of.
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
Tumor Suppressors Versus Oncogenes. The Cancer Phenotype is Usually Recessive R. Weinberg, Cancer Biology.
BRCA1 and Breast Cancer Madeline Ryan 3/17/2015.
The Cell Cycle Gone Awry Cancer and Mitosis. Mutagens give rise to cancer cells. There are a wide variety of mutagens which cause changes to our DNA:
Special Topics in Modern Genetics: Epigenetics Honors Genetics Ms. Susan Chabot.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Breast Cancer and BRCA2. 1 million women worldwide diagnosed. 1 out of 12 women in Western Europe and the United States 30% mortality rate Highest cause.
Apoptosis in Cancer By: Karen Hutcherson Ryan Jenkins Angie Lam Jennie Zaborsky ISAT
Benign Versus Malignant Tumors
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Section S Tumor viruses and oncogenes
Lecture 28 Genetics of Cancer Copyright © 2010 Pearson Education Inc.
BRCA2: Breast Cancer Susceptibility Gene 2 Lindy Behrend March 4, 2003.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
TSC1 and Facial Angiofibromas
Natasha Adlakha Bio445. Discovery in Breast Cancer Reverse Genetics BReast CAncer Gene Chromosome 13 Tumor suppressor gene Penetrance Familial,
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
Tumor Suppressor Gene Involved in Breast and Ovarian Cancers SCIENCE96/gene.cgi?BRCA1.
Types of Genes Associated with Cancer
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
© 2012 Pearson Education, Inc. Lecture by Edward J. Zalisko PowerPoint Lectures for Campbell Biology: Concepts & Connections, Seventh Edition Reece, Taylor,
HCDC4 & Endometrial Carcinoma Diana Rhyne. hCDC4 – Gene Information  Homologs in S. cervisiae, Drosophilia, and C. elegans  Tumor Suppressor  Expressed.
CANCER MODULE Units 1.3, 2.2, 2.3, 2.4, 2.5. REGULATION OF THE CELL CYCLE Drivers Checkpoints Divide!!Don’t divide!!
Cell Growth & Division Control of Cell Cycle | Disruptions to Cell Cycle.
Karyotyping Cancer.
GENETIC BASIS OF CANCER
p53 function and regulation in normal cells and cancer cells
The Genetic Basis of Cancer
Figure: Caption: The cell cycle is controlled at several checkpoints, including one at the G2/M transition, and another in late G1 phase before.
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
BRCA1 Breast Cancer.
What makes a mutant?.
Tumor Promoting Inflammation
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
Fibroblast Growth Factor 3 (FGF3) int-2
Genomic Instability and Cancer
Chapter 17: Regulation of cell number
B lymphocytes produce antibodies.
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
PTEN Tumor Suppressor and Cancer
FANCF methylation contributes to chemoselectivity in ovarian cancer
Ataxia telangiectasia and the Role of ATM
Specific Tumor Suppressor Genes
Tenets of PTEN Tumor Suppression
Presentation transcript:

BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.

BRCA 1 Overview Tumor suppressor largely expressed in mammary epithelial cells. Inheritance pattern similar to Rb. Mutated in ≈ 10% of breast/ovarian cancers. BRCA1 (+/-) women have lifetime risk of breast cancer ≈ 80%. BRCA1 cancers: high-grade, infiltrative tumors, usually aneuploid and estrogen receptor negative. Main function of wt BRCA 1 is DNA Repair.

Pathology of breast cancer in women carrying mutations in BRCA1 and BRCA2 Taken from the Breast Cancer Linkage Consortium (1997)

Genetics Cloned in 1994 Mapped to 17q21. Analogs in mouse, E. coli. Follows Knudson two-hit model: LOF of 2nd BRCA1 allele is required for cancer. However, BRCA1 homozygous mutants are not found in sporadic breast cancers.

east_cancer/ Genetics Ways to inactivate BRCA1: 1.Mutation – a number of single AA substitutions are known, most of which lead to protein truncation. (common) 2.Deletion of BRCA portion of Chromosome 17. (common) 3.Epigenetic silencing – methylation of certain BRCA1 residues (10% of the time)

BRCA1 gene copy number and protein expression analysis on breast tumor section. Tumor cells in a BRCA1 methylated sample are seen to have reduced BRCA1 gene copy numbers (red signal) compared with centromere 17 (green signal) by FISH. Birgisdottir et al., Breast Cancer Research 2006, 8:R38

Protein Structure Source - Breast cancer genetics: What we know and what we need May 2001,vol 7,no.5 pp (Nature)Nature C-terminal BRCT domain Internal SQ Cluster domain N-terminal “ring finger” domain

Functions of BRCA1: Double-Stranded DNA Break Repair Homologous Recombination BRCA1 structure facilitates binding of 4 DNA strands. When subjected to ionizing radiation or oxidative stress, BRCA1 (-/-) cells cannot mediate the DS breakage and/or cross-linking that occurs. BRCA1 is required for 3’ -OH invasion of template (red) strand

Other functions of BRCA1: Mediate Cell Cycle Checkpoints at S and G2/M Ubiquitination Apoptosis Regulation of DNA Replication

BRCA 1 Protein Function BRCA1 null mouse embryos die early in development. Total loss of BRCA1 also triggers p53-dependent growth arrest. Because of BRCA1’s role in DNA repair, p53 normally senses its loss and halts proliferation. In BRCA1 (-/-) embryos, subsequent p53 inactivation allowed them to proceed in development.

BRCA 1 Protein Function BRCA1 (-/-) adult mice developed mammary tumors with frequent p53 mutations. In 90% of human breast cancers where BRCA1 has been inactivated, p53 has been inactivated as well.

Clinical Applications CisplatinCisplatin CisplatinCisplatin Many BRCA1 carriers opt to undergo prophylactic bilateral mastectomy and/or hysterectomy. Cisplatin, a chemotherapeutic agent, targets BRCA1 deficient cells by causing DNA crosslinking Resveratrol, a phytochemical found in berries, has anti-cancer properties that likely involve the BRCA1/p53 apoptotic pathway. Cisplatin “Cisplatin”, “Resveratrol” Resveratrol

Sources 1.Powell, Simon N. and Kachnic, Lisa A. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene. Issue 22, “Cisplatin.” Microsoft Internet Explorer, accessed 25 February Birgisdottir, V. et al. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Research. Issue 8, 17 July Gowen LC et al. BRCA1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nature Genetics. Issue 12, February 1996, Holland, Frei et al. “Breast-Ovarian Cancer Syndrome.” Cancer Medicine. London: BC Decker Inc “BRCA1 – ID# ” Online Mendelian Inheritance in Man. Microsoft Internet Explorer, accessed 23 February